Article Information
History
- September 22, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Trishna A Desai1,*,
- Åsa K Hedman2,3,
- Marios Dimitriou2,3,
- Mine Koprulu4,
- Sandy Figiel5,
- Wencheng Yin5,
- Mattias Johansson6,
- Eleanor L Watts7,
- Joshua R Atkins1,
- Aleksandr V Sokolov8,
- Helgi B Schiöth8,
- Marc J Gunter6,9,
- Konstantinos K Tsilidis9,10,
- Richard M Martin11,12,13,
- Maik Pietzner4,14,15,
- Claudia Langenberg4,14,15,
- Ian G Mills5,
- Alastair D Lamb5,
- Anders Mälarstig2,3,
- Tim J Key1,
- The PRACTICAL Consortium,
- Ruth C Travis1,* and
- Karl Smith-Byrne1,*
- 1Cancer Epidemiology Unit, Oxford Population Health, University of Oxford, Oxford, United Kingdom
- 2External Science and Innovation, Pfizer Worldwide Research, Development and Medical, Stockholm, Sweden,
- 3Department of Medicine, Department of Medicine, Stockholm, Sweden,
- 4MRC Epidemiology Unit, University of Cambridge, United Kingdom
- 5University of Oxford, Nuffield Department of Surgical Sciences, Oxford, United Kingdom
- 6Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France
- 7Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America
- 8Department of Surgical Sciences, Functional Pharmacology and Neuroscience Uppsala University, 75124 Uppsala, Sweden
- 9Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary’s Campus, Norfolk Place, London, W2 1PG, United Kingdom
- 10Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
- 11Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
- 122MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom
- 13NIHR Bristol Biomedical Research Centre, Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom
- 14Computational Medicine, Berlin Institute of HealthHealth (BIH) at Charité - Univeritätsmedizin– Universitätsmedizin Berlin, Berlin, Germany
- 15Precision Healthcare University Research Institute, Queen Mary University of London, London, United Kingdom
- ↵* Corresponding author; email: trishna.desai{at}ndph.ox.ac.uk
↵* These authors contributed equally.
Posted September 22, 2023.
Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics
